Bicara Therapeutics Inc. (BCAX) Profit Breakdown
- 2026-06-30: Reportable -$55.38M.
- 2025-06-30: Reportable -$27.34M.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2023-03-31 to 2026-06-30
- Data captured
Profit by product
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | -$55.38M |
|---|
| 2025-06-30 | -$27.34M |
|---|
Net Income (Loss) Attributable to Parent: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | -$55.44M |
|---|
| 2025-06-30 | -$27.39M |
|---|
Nonoperating Income (Expense): each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $4.58M |
|---|
| 2025-06-30 | $4.68M |
|---|
Operating income: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | -$59.95M |
|---|
| 2025-06-30 | -$32.02M |
|---|